Neil Kumar, Chief Executive Officer at BridgeBio Pharma, Inc. (BBIO), sold 10,000 shares at $69.01 ($691K) on 2026-09-17, disclosed to the SEC on 2026-09-21.
Scheduled sale ($691k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.01 | 8,721 | $602K | 87.1% |
| 2 | $69.57 | 1,279 | $89K | 12.9% |
| Total | $69.08 avg | 10,000 | $691K | 100% |
| Filing → |
| BBIO | SELL | 2026-05-26 | $1.8M | — | Filing → |
| BBIO | SELL | 2026-05-11 | $5.3M | — | Filing → |
| BBIO | SELL | 2026-04-13 | $6.0M | — | Filing → |